top of page

NCI-2015-00014

Updated: Feb 21

I-SPY TRIAL: Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2.


This research study aims to predict how well different cancer treatments will work for individual patients. They do this by using advanced imaging techniques and analyzing the patient's cancer cells at a molecular level. By understanding these details, doctors hope to better predict how patients will respond to different treatments, leading to more effective and personalized care.


For more information about the trial, click the link below:

Clinical Trial Site: Einstein/Columbia


To see all available clinical trials click here.



 
 
 

Recent Posts

See All
NCI-2024-07005

A Phase 1a/1b Study of LY4052031, an Antibody-Drug Conjugate Targeting Nectin-4, in Participants with Advanced or Metastatic Urothelial...

 
 
 
NCI-2024-02382

A Platform Study of RAS(ON) Inhibitor Combinations in Patients with RAS-Mutated Non-Small Cell Lung Cancer (NSCLC) This is a platform...

 
 
 
NCI-2024-06081

A PHASE 1B/2, MULTICENTER, OPEN-LABEL STUDY OF IFINATAMAB DERUXTECAN (I-DXd), A B7-H3 ANTIBODY-DRUG CONJUGATE (ADC), IN COMBINATION WITH...

 
 
 

Kommentare


bottom of page